BSG and liver cancer: Once azo‐bond was reduced under hypoxia, a self‐immolative reaction releases PEG5000, and HAP18 Ab is allowed to target CD147 in hypoxic liver cancer, thus eradicating the on‐target off‐tumor toxicity.